Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Short term Debt (2020 - 2024)

Cumberland Pharmaceuticals' Short term Debt history spans 4 years, with the latest figure at $5.1 million for Q4 2024.

  • For Q4 2024, Short term Debt changed N/A year-over-year to $5.1 million; the TTM value through Dec 2024 reached $5.1 million, changed N/A, while the annual FY2024 figure was $5.1 million, N/A changed from the prior year.
  • Short term Debt for Q4 2024 was $5.1 million at Cumberland Pharmaceuticals, down from $6.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $6.0 million in Q3 2024 and bottomed at $2.0 million in Q3 2020.